| Jennifer Berman, | |
|
2701 N Decatur Rd, Decatur, GA 30033-5918 | |
| (404) 501-1849 | |
| Not Available |
| Full Name | Jennifer Berman |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 2701 N Decatur Rd, Decatur, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386854768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 059124 (Georgia) | Primary |
| Entity Name | The Bortolazzo Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801965082 PECOS PAC ID: 3476554320 Enrollment ID: O20070122000015 |
News Archive
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge, and the AstraZeneca IMED Biotech Unit reveals new insights into how the PTEN gene may control cell growth and behavior and how its loss contributes to the development and advancement of certain cancers.
GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).
Kids and teens often think they know what's best. When it comes to preventing childhood obesity, maybe we should listen to them, says Baker Harrell, executive director of ACTIVE Life, a non-profit organization that seeks to combat obesity with social activism.
A bacterial by-product known to be important in maintaining gut health may slow the progression of amyotrophic lateral sclerosis, or ALS - a progressive, neurodegenerative disease.
New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.
› Verified 8 days ago
| Entity Name | Cep America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124073721 PECOS PAC ID: 6608056171 Enrollment ID: O20121126000128 |
News Archive
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge, and the AstraZeneca IMED Biotech Unit reveals new insights into how the PTEN gene may control cell growth and behavior and how its loss contributes to the development and advancement of certain cancers.
GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).
Kids and teens often think they know what's best. When it comes to preventing childhood obesity, maybe we should listen to them, says Baker Harrell, executive director of ACTIVE Life, a non-profit organization that seeks to combat obesity with social activism.
A bacterial by-product known to be important in maintaining gut health may slow the progression of amyotrophic lateral sclerosis, or ALS - a progressive, neurodegenerative disease.
New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Berman, 2100 Powell St, Suite 900, Emeryville, CA 94608-1826 Ph: (510) 350-2663 | Jennifer Berman, 2701 N Decatur Rd, Decatur, GA 30033-5918 Ph: (404) 501-1849 |
News Archive
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge, and the AstraZeneca IMED Biotech Unit reveals new insights into how the PTEN gene may control cell growth and behavior and how its loss contributes to the development and advancement of certain cancers.
GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).
Kids and teens often think they know what's best. When it comes to preventing childhood obesity, maybe we should listen to them, says Baker Harrell, executive director of ACTIVE Life, a non-profit organization that seeks to combat obesity with social activism.
A bacterial by-product known to be important in maintaining gut health may slow the progression of amyotrophic lateral sclerosis, or ALS - a progressive, neurodegenerative disease.
New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.
› Verified 8 days ago
Dr. Richard Edward Wild, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1275 Oak Grove Dr, Decatur, GA 30033 Phone: 404-315-6110 Fax: 404-315-6074 | |
Dr. Richard Yao Chang Kwong, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2701 N Decatur Rd, Department Of Emergency Medicine, Decatur, GA 30033 Phone: 404-501-1000 Fax: 404-501-1765 | |
Dr. Andrew D Jones, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2701 N Decatur Rd, Attn: Stephanie Rowe, Decatur, GA 30033 Phone: 404-501-2650 Fax: 404-501-1765 | |
Tiencia Dorothea James, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2701 N Decatur Rd, Decatur, GA 30033 Phone: 404-501-1849 | |
Adam Marchak, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2701 N Decatur Rd, Decatur, GA 30033 Phone: 404-501-5374 | |
Joy Felicia Slade, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2701 North Decatur Road, Decatur, GA 30033 Phone: 404-501-1849 | |
Leli Gail Matthews, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2701 N Decatur Rd, Decatur, GA 30033 Phone: 404-501-1849 |